Development of MR-based biomarker panels for NAFLD - A NASH CRN Ancillary Study

开发基于 MR 的 NAFLD 生物标志物组合 - NASH CRN 辅助研究

• 批准号: 8144070
• 负责人: CLAUDE B SIRLIN
• 金额: $ 59.73万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-09-30 至 2012-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8144070
• 关键词: Adipose tissue; Adult; Affect; Agreement; American; Ancillary Study; Biochemical; Biological Markers; Biopsy; Cardiovascular Diseases; Caring; Child; Childhood; Chronic; Cirrhosis; Classification; Clinical; Clinical Research; Clinical Trials; Contrast Media; Data; Development; Diabetes Mellitus; Diagnosis; Diagnostic; Diffusion; Disease; Early Diagnosis; Enrollment; Epidemiology; Evaluation; Extrahepatic; Fatty acid glycerol esters; Fibrosis; Genetic; Goals; Health; Hepatic; Histologic; Histology; Hour; Individual; Insulin Resistance; Intervention; Letters; Liver; Liver Fibrosis; Liver diseases; Magnetic Resonance; Magnetic Resonance Elastography; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Malignant neoplasm of liver; Measurement; Measures; Mechanics; Methods; Modeling; Monitor; Natural History; Obesity; Patients; Performance; Perfusion; Persons; Physiological; Population Heterogeneity; Process; Property; Reference Standards; Relaxation; Reproducibility; Research; Research Subjects; Risk; Sensitivity and Specificity; Serum; Site; Staging; Techniques; Therapeutic Intervention; Tissues; United States; Variant; age group; base; clinical care; clinical decision-making; clinical practice; design; diagnostic accuracy; improved; liver biopsy; non-alcoholic fatty liver; nonalcoholic steatohepatitis; outcome forecast; pre-clinical; prospective; public health relevance; response; viscoelasticity